From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Medicina intensiva - 44(2020), 8 vom: 15. Nov., Seite 509-512 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Del empirismo a la evidencia científica en el tratamiento con antivíricos en los casos graves de infección por coronavirus en tiempos de epidemia |
---|
Beteiligte Personen: |
Estella, Á [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 19.11.2020 Date Revised 24.05.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.medin.2020.04.009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310061725 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM310061725 | ||
003 | DE-627 | ||
005 | 20231225135257.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.1016/j.medin.2020.04.009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1033.xml |
035 | |a (DE-627)NLM310061725 | ||
035 | |a (NLM)32423569 | ||
035 | |a (PII)S0210-5691(20)30116-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Estella, Á |e verfasserin |4 aut | |
245 | 1 | 0 | |a From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic |
246 | 3 | 3 | |a Del empirismo a la evidencia científica en el tratamiento con antivíricos en los casos graves de infección por coronavirus en tiempos de epidemia |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.11.2020 | ||
500 | |a Date Revised 24.05.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Drug Combinations |2 NLM | |
650 | 7 | |a lopinavir-ritonavir drug combination |2 NLM | |
650 | 7 | |a Lopinavir |2 NLM | |
650 | 7 | |a 2494G1JF75 |2 NLM | |
650 | 7 | |a remdesivir |2 NLM | |
650 | 7 | |a 3QKI37EEHE |2 NLM | |
650 | 7 | |a Adenosine Monophosphate |2 NLM | |
650 | 7 | |a 415SHH325A |2 NLM | |
650 | 7 | |a Hydroxychloroquine |2 NLM | |
650 | 7 | |a 4QWG6N8QKH |2 NLM | |
650 | 7 | |a Chloroquine |2 NLM | |
650 | 7 | |a 886U3H6UFF |2 NLM | |
650 | 7 | |a Ritonavir |2 NLM | |
650 | 7 | |a O3J8G9O825 |2 NLM | |
650 | 7 | |a Alanine |2 NLM | |
650 | 7 | |a OF5P57N2ZX |2 NLM | |
700 | 1 | |a Garnacho-Montero, J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicina intensiva |d 2017 |g 44(2020), 8 vom: 15. Nov., Seite 509-512 |w (DE-627)NLM25948640X |x 2173-5727 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2020 |g number:8 |g day:15 |g month:11 |g pages:509-512 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medin.2020.04.009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2020 |e 8 |b 15 |c 11 |h 509-512 |